# CPAP for Hypoxemic Acute Chest Syndrome in Sickle Cell Disease

> **NCT07703566** · NA · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 140 (estimated)

## Conditions studied

- Sickle Cell Disease (SCD)
- Acute Chest Syndrome (ACS)

## Interventions

- **OTHER:** O2+CPAP group

## Key facts

- **NCT ID:** NCT07703566
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-10-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07703566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07703566, "CPAP for Hypoxemic Acute Chest Syndrome in Sickle Cell Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07703566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*